Association of Baseline Hyperglycemia With Outcomes of Patients With and Without Diabetes With Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Propensity Score–Matched Analysis From the SITS-ISTR Registry

Available data from observational studies on the association of admission hyperglycemia (aHG) with outcomes of patients with acute ischemic stroke (AIS) treated with intravenous thrombolysis (IVT) are contradictory, especially when stratified by diabetes mellitus (DM) history. We assessed the association of aHG (≥144 mg/dL) with outcomes stratified by DM history using propensity score–matched (PSM) data from the SITS-ISTR. The primary safety outcome was symptomatic intracranial hemorrhage (SICH); 3-month functional independence (FI) (modified Rankin Scale [mRS] scores 0–2) represented the primary efficacy outcome. Patients with and without aHG did not differ in baseline characteristics both in the non-DM (n = 12,318) and DM (n = 6,572) PSM subgroups. In the non-DM group, patients with aHG had lower 3-month FI rates (53.3% vs. 57.9%, P < 0.001), higher 3-month mortality rates (19.2% vs. 16.0%, P < 0.001), and similar symptomatic intracerebral hemorrhage (SICH) rates (1.7% vs. 1.8%, P = 0.563) compared with patients without aHG. Similarly, in the DM group, patients with aHG had lower rates of 3-month favorable functional outcome (mRS scores 0–1, 34.1% vs. 39.3%, P < 0.001) and FI (48.2% vs. 52.5%, P < 0.001), higher 3-month mortality rates (23.7% vs. 19.9%, P < 0.001), and similar SICH rates (2.2% vs. 2.7%, P = 0.224) compared with patients without aHG. In conclusion, aHG was associated with unfavorable 3-month clinical outcomes in patients with and without DM and AIS treated with IVT.

[1]  H. Chandalia,et al.  STRESS HYPERGLYCAEMIA , 1984, The Lancet.

[2]  G. Murray,et al.  Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study , 1997, BMJ.

[3]  P Trouillas,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.

[4]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[5]  Mark W Parsons,et al.  Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study , 2002, Annals of neurology.

[6]  J. Arenillas,et al.  Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated Patients , 2003, Stroke.

[7]  R. Roine,et al.  Hyperglycemia in Acute Stroke , 2004, Stroke.

[8]  F. Vancheri,et al.  Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. , 2005, QJM : monthly journal of the Association of Physicians.

[9]  A. Alexandrov,et al.  Outcome in hyperglycemic stroke with ultrasound-augmented thrombolytic therapy , 2006, Neurology.

[10]  P. Chan,et al.  Influence of Hyperglycemia on Oxidative Stress and Matrix Metalloproteinase-9 Activation After Focal Cerebral Ischemia/Reperfusion in Rats: Relation to Blood-Brain Barrier Dysfunction , 2007, Stroke.

[11]  P. Sandercock,et al.  Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK) , 2007, The Lancet Neurology.

[12]  Gary King,et al.  Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference , 2007, Political Analysis.

[13]  Werner Hacke,et al.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.

[14]  Gary A. Ford,et al.  Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) , 2008, Stroke.

[15]  Sumit R. Majumdar,et al.  Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis , 2008, Diabetes Care.

[16]  G. Biessels,et al.  Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management , 2010, Nature Reviews Neurology.

[17]  M. Kaste,et al.  Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). , 2010, Archives of neurology.

[18]  M. Kaste,et al.  Symptomatic intracranial hemorrhage after stroke thrombolysis: The SEDAN Score , 2012, Annals of neurology.

[19]  Gary A. Ford,et al.  Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase: Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score , 2012, Stroke.

[20]  S. Tokuyama,et al.  Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter , 2012, Brain Research.

[21]  C. Nolte,et al.  Glycosylated Hemoglobin A1 Predicts Risk for Symptomatic Hemorrhage After Thrombolysis for Acute Stroke , 2013, Stroke.

[22]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[23]  K. Muir,et al.  Hyperglycemia Accelerates Apparent Diffusion Coefficient-Defined Lesion Growth after Focal Cerebral Ischemia in Rats with and Without Features of Metabolic Syndrome , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  R. Swanson,et al.  Opposing Effects of Glucose on Stroke and Reperfusion Injury: Acidosis, Oxidative Stress, and Energy Metabolism , 2014, Stroke.

[25]  Å. Sjöholm,et al.  GLP-1R activation for the treatment of stroke: Updating and future perspectives , 2014, Reviews in Endocrine and Metabolic Disorders.

[26]  Xuechu Zhen,et al.  Neuropharmacological Actions of Metformin in Stroke , 2015, Current neuropharmacology.

[27]  Eric E. Smith,et al.  Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post‐Thrombolysis: Findings From Get With The Guidelines‐Stroke , 2015, Journal of the American Heart Association.

[28]  Valerie Durkalski,et al.  The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study , 2015, Trials.

[29]  S. Tokuyama,et al.  Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia , 2015, Neuroscience.

[30]  D. Leys,et al.  Influence of glycaemic control on the outcomes of patients treated by intravenous thrombolysis for cerebral ischaemia , 2015, Journal of Neurology.

[31]  A. Alexandrov,et al.  Admission hyperglycemia and outcomes in large vessel occlusion strokes treated with mechanical thrombectomy , 2017, Journal of NeuroInterventional Surgery.

[32]  J. Dawson,et al.  Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis , 2017, Stroke.

[33]  D. Strbian,et al.  Intravenous Thrombolysis for Ischemic Stroke Patients on Dual Antiplatelets , 2018, Annals of Neurology.

[34]  Hai-bin Shi,et al.  Effects of Diabetes Mellitus and Admission Glucose in Patients Receiving Mechanical Thrombectomy: A Systematic Review and Meta-analysis , 2018, Neurocritical Care.

[35]  J. Putaala,et al.  European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke , 2018, European stroke journal.

[36]  H. Tammen,et al.  The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway , 2018, Cardiovascular Diabetology.

[37]  Yu Sun,et al.  Hyperglycemia predicts unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis among a Chinese population: A prospective cohort study , 2018, Journal of the Neurological Sciences.

[38]  15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[39]  L. Uhlmann,et al.  Predictors of symptomatic intracranial haemorrhage in off‐label thrombolysis: an analysis of the Safe Implementation of Treatments in Stroke registry , 2018, European journal of neurology.

[40]  D. Toni,et al.  STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke , 2018, Stroke.